.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
You must login to ask a question.
Sorry, you do not have permission to add post.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
1. Gram-negative intra-cellular diplococci.
2. Neisseria meningitidis (meningococcus) has a prominent polysaccharide capsule that enhances virulence through its complement inhibitory and antiphagocytic action. Nonencapsulated N. meningitidis isolates are generally considered nonpathogenic. The capsule is also the immunogen in the meningococcal vaccine.
3. Serogroups: Based on the antigenic nature of capsular polysaccharides, N. meningitidis can be typed into 13 serogroups (A-D, X-Z, 29E, W135, H-J, and L). Six serogroups (types) of Neisseria meningitidis A, B, C, W, X, and Y cause the majority of cases of IMDs worldwide.
Serotype A was the leading cause of epidemic meningitis worldwide, mainly in the African meningitis belt.